Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2026-03-03 @ 3:06 PM
Study NCT ID:
NCT03418532
Status:
TERMINATED
Last Update Posted:
2023-03-23
First Post:
2018-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC
Sponsor:
Organization: